1. Articles from Julia La Roche

    1-24 of 45 1 2 »
    1. Bill Ackman is Hosting a Webcast for his Infamous Herbalife Short

      Bill Ackman is Hosting a Webcast for his Infamous Herbalife Short

      Billionaire activist investor Bill Ackman, the CEO of $13 billion Pershing Square Capital, is hosting a webcast on Herbalife, his infamous short position. The webcast features a video called "The American Dream Denied: Herbalife Victims Speak Out".  "Herbalife claims it cleaned up its act after we exposed its fraudulent business model," Pershing Square said on the webpage...

      Read Full Article
    2. Bill Ackman is Getting Crushed, Again

      Bill Ackman is Getting Crushed, Again

      Reuters/ Jack Cusano Hedge fund titan Bill Ackman's Pershing Square Holdings, the fund's publicly traded vehicle, has fallen 11.4% in 2016, according to a performance update. That performance is through January 12.  Pershing Square had its worst year in its history last year, falling 20.5%.  Ackman, a well-known activist investor, makes large bets in a handful companies. His largest holdings ...

      Read Full Article
    3. Third Avenue's CEO Departs After Liquidating High Yield Bond Fund and isn't Allowed in the firm's Building

      Third Avenue's CEO Departs After Liquidating High Yield Bond Fund and isn't Allowed in the firm's Building

      On Thursday, Third Avenue Management's CEO David Barse wrote to the fund's shareholders that the firm was shuttering its embattled Focused Credit Fund.  The letter said the fund plans to liquidate the high yield bond fund on December 16. It also noted that it would not allow further investor redemptions...

      Read Full Article
    4. SolarCity's Stock Just Spiked After News of a $100 million Investment From Private Equity Giant Silver Lake

      SolarCity's Stock Just Spiked After News of a $100 million Investment From Private Equity Giant Silver Lake

      Shares of SolarCity climbed more than 6% in the premarket on news that private equity giant Silver Lake Partners will announce a large, new investment in the solar power company later today.  Dealbook's Michael J. de la Merced reports that  Silver Lake Kraftwerk, the private equity firm's clean energy investment arm, will announce a $100 million investment in SolarCity's convertible notes on Wednesday...

      Read Full Article
      Mentions: Investment
    5. A Hedge Fund Manager Perfectly Captured What Bill Ackman is Going Through as Valeant Crashes

      A Hedge Fund Manager Perfectly Captured What Bill Ackman is Going Through as Valeant Crashes

      Hedge fund manager Whitney Tilson sent around an e-mail yesterday that captures what  activist investor Bill Ackman is going through with his massive money-losing investment in Valeant Pharmaceuticals. Here's his take (emphasis is ours):   "Every investor should analyze this case study to learn from Ackman’s experience, as every last one of us has had (and will have) to deal with a major ...

      Read Full Article
    6. Bill Ackman Defends his Big Money-Losing Bet in Valeant

      Bill Ackman Defends his Big Money-Losing Bet in Valeant

      Billionaire activist investor Bill Ackman, founder of Pershing Square Capital, is hosting a conference call for investors to discuss his fund's large investment in Valeant Pharmaceuticals. Ackman began the call by saying that they've had more participants than expected. He said the reason they're holding the call is for transparency. He then went into a broad overview of the company and its ...

      Read Full Article
    7. Valeant's Largest Shareholder: 'It hurts'

      Valeant's Largest Shareholder: 'It hurts'

      Sequoia Fund, the large mutual fund managed by Robert Goldfarb and David Poppe, has posted a letter on the homepage of its website defending its massive investment in Valeant Pharmaceuticals.  Shares of the Canadian drug company have collapsed since last Wednesday. That is when Citron Research, the short-selling firm run by Andrew Left, published a report asking whether Valeant was operating an Enron-like fraud.  Valeant's share price has declined by more than 40% since the report came out...

      Read Full Article
    8. Bill Ackman is Hosting a Call on Friday to talk about his Huge Money-Losing Bet on Valeant

      Bill Ackman is Hosting a Call on Friday to talk about his Huge Money-Losing Bet on Valeant

      Billionaire activist investor Bill Ackman, the founder of Pershing Square Capital,  is hosting a conference call for investors on Friday morning to discuss his fund's investment in Valeant Pharmaceuticals.  The call will take place at 9 a.m.  ET. Ackman and other Pershing Square portfolio managers and analysts will take questions. Since taking a position earlier this year, Pershing Square has ...

      Read Full Article
    9. Valeant is Holding an All-Hands on Deck Call to Address Allegations Made by a Short Seller

      Valeant is Holding an All-Hands on Deck Call to Address Allegations Made by a Short Seller

      Canadian pharmaceutical company Valeant is hosting a conference call on Monday to address allegations made by a short-selling research firm.  The participants on the call include CEO Michael Pearson, general counsel Robert Chai-Onn, CFO Rober Rosiello, and a number of board members and risk committee members.  10 Valeant executives will be on the call in total...

      Read Full Article
      Mentions: General Counsel CEO
    10. Bill Ackman May Have Lost Close to $2 Billion on his Big Valeant Bet

      Bill Ackman May Have Lost Close to $2 Billion on his Big Valeant Bet

      Hedge fund manager Bill Ackman has potentially lost close to $2 billion on paper on his hedge fund's largest stock holding.  Canadian drug company Valeant Pharmaceuticals is getting hammered after short-selling firm Citron Research published a report comparing it to Enron.  Valeant's share price was last trading down 30% at about $102. The stock had fallen as low as $98.35...

      Read Full Article
    11. Bill Ackman's Hedge Fund had a Brutal Month

      Bill Ackman's Hedge Fund had a Brutal Month

      Pershing Square Capital, the $20 billion fund run by activist investor Bill Ackman, got crushed in September.  The fund fell 12.5% during the month. It's now down 12.6% for the first nine months of this year, according to a performance update.  Ackman's returns were largely dragged down by the fund's large stake in Valeant Pharmaceuticals...

      Read Full Article
    12. Bill Ackman's Biggest Stock Holding is Getting Hammered

      Bill Ackman's Biggest Stock Holding is Getting Hammered

      Activist investor Bill Ackman's biggest stock holding is getting demolished.  Shares of Valeant Pharmaceuticals plummeted  on Monday  after  Democrats on the  House Oversight  and Government Reform Committee sent a letter to the committee's chairman,  Jason  Chaffetz (R-UT), asking him to subpoena the pharmaceutical company for documents related to price increases of acquired drugs, Bloomberg ...

      Read Full Article
    13. Bill Ackman is Eyeing Another Huge and Potentially Controversial Deal

      Bill Ackman is Eyeing Another Huge and Potentially Controversial Deal

      Billionaire activist investor Bill Ackman, the founder of $19 billion Pershing Square, said it's "very likely" that he will do another deal similar to the controversial sale of Allergan in 2014.  "What we did in Allergan was we called the question and allowed shareholders to decide what they wanted to do with the future of their business. And I think that there are acquirers who would like to ...

      Read Full Article
    14. Bill Ackman's Gains for the Year Got Wiped Out in a Matter of Weeks

      Bill Ackman's Gains for the Year Got Wiped Out in a Matter of Weeks

      Pershing Square Holdings, the $7.4 billion publicly-traded vehicle led by Bill Ackman, has erased all of its gains in a matter of weeks and is now down for the year. Ackman said in  an investor update : "However there has been significant volatility in the investment markets over the past few weeks, largely driven by the decline of the Chinese stock markets, and the fear that slowing growth in ...

      Read Full Article
      Mentions: Investment
    15. We're Not the 'Corporate Raiders' of The 1980s

      We're Not the 'Corporate Raiders' of The 1980s

      Hedge fund manager Daniel Loeb, the founder of Third Point LLC, has hit back at the those taking aim at activist investing. Loeb, one of the most prominent activist investors of his generation, defended the strategy in his second quarter letter to investors. The strategy has generated bumper returns for investors over the years, but has recently faced criticism from the likes of Blackrock chief executive Larry Fink and Democratic presidential candidate Hillary Clinton...

      Read Full Article
    16. There's a Billionaire Hedge Fund Manager in the New Google CFO's Wall Street Fanclub

      There's a Billionaire Hedge Fund Manager in the New Google CFO's Wall Street Fanclub

      Billionaire hedge fund manager Leon Cooperman, the founder of $10 billion Omega Advisors, is super bullish on Google and its new CFO. The 72-year-old investor said in his fund's second-quarter letter that he snapped up a position in the tech giant in mid-April. He bought in when Google was trading at $602 per share. They're currently trading above $655, which represents a return of almost 9% in a little over three months...

      Read Full Article
      Mentions: Hedge Fund
    17. McDonald's Culture 'Has To Be Turned Upside Down'

      McDonald's Culture 'Has To Be Turned Upside Down'

      Activist titans Nelson Peltz of Trian Fund Management and Bill Ackman of Pershing Square weighed in on how to fix McDonald's. The largest global fast-food chain has struggled in recent years, especially in the US. At the CNBC/Institutional Investor Delivering Alpha Conference, "Mad Money" host Jim Cramer asked the two hedge fund billionaires if they could fix McDonald's...

      Read Full Article
    18. The Hedge Fund Manager Behind the Epic Olive Garden Presentation is Going after Macy's and the Stock Just Jumped

      The Hedge Fund Manager Behind the Epic Olive Garden Presentation is Going after Macy's and the Stock Just Jumped

      Starboard Value's Jeff Smith recommended Macy's at the CNBC/Institutional Investor's Delivering Alpha Conference at the Pierre Hotel in New York City. This is the first time the activist investor is disclosing the position. The stock jumped more than 4.8% after Smith announced the position. Smith thinks Macy's is undervalued. He pointed out that the retailer's stock currently trades around $66 per share. Smith thinks it's worth in excess of $125 per share...

      Read Full Article
    19. The Most 'Interesting' Investment in Bill Ackman's Portfolio That 'No One's Really Noticed'

      The Most 'Interesting' Investment in Bill Ackman's Portfolio That 'No One's Really Noticed'

      Activist investor Bill Ackman, the CEO of $18 billion Pershing Square Capital Management, said the most interesting investment in his portfolio right now are mortgage originators Fannie Mae and Freddie Mac. The 49-year-old activist investor was on a panel his friend and fellow activist investor Nelson Peltz, the CEO of Trian Fund Management at the CNBC/Institutional Investor Delivering Alpha Conference at the Pierre Hotel in New York...

      Read Full Article
    1-24 of 45 1 2 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics in the News

    1. (24 articles) CEO
    2. (23 articles) Hedge Fund
    3. (22 articles) Board of directors
    4. (13 articles) Management
    5. (11 articles) Investment
    6. (7 articles) activist investors
    7. (7 articles) Investors
    8. (7 articles) Board of directors
    9. (7 articles) Board
    10. (6 articles) hostile takeover
    11. (4 articles) Valeant Pharmaceuticals
    12. (4 articles) SEC
    13. (4 articles) NYSE
    14. (3 articles) Nasdaq
    15. (1 articles) Elliot K. Fullen
    16. (1 articles) Don Butler
    17. (1 articles) Independent Director
    18. (1 articles) Rexnord Corporation
    19. (1 articles) Arcadia Biosciences
    20. (1 articles) Ford
  3. Popular Articles

  4. Picture Gallery

    Dan Loeb Is Giving A Rare Interview Right Now Dan Loeb Takes A New Stake In Dow Chemical And It's Now Third Point's Largest Positon Herbalife Is Exploding Higher On News That The Stock's Biggest Bull is Joining Forces With An Outside Investor Carl Icahn Gives Up On Apple Buyback Plan It Looks Like Bill Ackman Just Got A Huge Ally In His Fight For Botox-Maker Allergan Bill Ackman Has Made Over $2.2 Billion On A Deal That's Arguably A Failure Jefferies CEO Rich Handler Turned Down his $2.17 Million Bonus Bill Ackman Has Two Undisclosed Positions, and One of Them is Massive Dan Loeb Turned $3 Million into a $17.5 Billion Hedge Fund Empire in 20 Years — Here's His Fabulous Life Bill Ackman Defends his Big Money-Losing Bet in Valeant Lumen Technologies (LUMN) Appoints Quincy L. Allen to its Board of Directors GRAY NAMES STERLING SPAINHOUR TO ITS BOARD OF DIRECTORS